These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation. Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and analgesic and anti-inflammatory activities 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(p-substituted/nonsubstituted benzal)hydrazone derivatives. Gökçe M; Utku S; Küpeli E Eur J Med Chem; 2009 Sep; 44(9):3760-4. PubMed ID: 19535179 [TBL] [Abstract][Full Text] [Related]
10. Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease. Geerts H IDrugs; 2007 Feb; 10(2):121-33. PubMed ID: 17285465 [TBL] [Abstract][Full Text] [Related]
11. P38 MAPK inhibitor semapimod reduces postoperative ileus via peripheral and central mechanisms. de Jonge WJ; The FO; Löwenberg M; Boeckxstaens GE Gastroenterology; 2009 May; 136(5):1841-2; author reply 1842. PubMed ID: 19303016 [No Abstract] [Full Text] [Related]
14. CNI-1493, an inhibitor of proinflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis. Larsson E; Harris HE; Palmblad K; Månsson B; Saxne T; Klareskog L Ann Rheum Dis; 2005 Mar; 64(3):494-6. PubMed ID: 15708902 [TBL] [Abstract][Full Text] [Related]
15. High-mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod. Zamora R; Grishin A; Wong C; Boyle P; Wang J; Hackam D; Upperman JS; Tracey KJ; Ford HR Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G643-52. PubMed ID: 15947118 [TBL] [Abstract][Full Text] [Related]
17. Iclaprim, a diaminopyrimidine dihydrofolate reductase inhibitor for the potential treatment of antibiotic-resistant staphylococcal infections. Peppard WJ; Schuenke CD Curr Opin Investig Drugs; 2008 Feb; 9(2):210-25. PubMed ID: 18246524 [TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of c-Raf activity by semapimod induces clinical remission in severe Crohn's disease. Löwenberg M; Verhaar A; van den Blink B; ten Kate F; van Deventer S; Peppelenbosch M; Hommes D J Immunol; 2005 Aug; 175(4):2293-300. PubMed ID: 16081798 [TBL] [Abstract][Full Text] [Related]